Pfizer Opens New $200-Million Clinical Mfg Facility for Biologics

By Patricia Van Arnum - DCAT Editorial Director

May 9, 2019

Pizer has opened a new 175,000-square-foot manufacturing facility in Andover, Massachusetts to support manufacture of clinical supplies for the company’s BioTherapeutics Pharmaceutical Sciences organization. Pfizer’s Andover site houses commercial manufacturing and product-development functions for biologics and vaccines. The new Andover Clinical Manufacturing Facility (ACMF) will expand the capacity for clinical supplies.

Pfizer’s ACMF investment is over $200 million and includes five independent manufacturing suites to advance Pfizer’s pipeline of potential new biotherapeutics and vaccines, which consists of more than 50 projects in development. The site will provide 75 new jobs to the approximately 2,000 employees currently based in Massachusetts.

Pfizer’s Andover campus currently includes seven buildings, which house laboratories, clinical and commercial manufacturing suites, and support areas. The new ACMF is a multiproduct manufacturing facility with a flexible design and advanced manufacturing technologies.

Source: Pfizer